- Home
- EMF vs LXRX Comparison
EMF vs LXRX Comparison
Compare EMF & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMF
- LXRX
- Stock Information
- Founded
- EMF 1987
- LXRX 1995
- Country
- EMF United States
- LXRX United States
- Employees
- EMF N/A
- LXRX N/A
- Industry
- EMF Finance/Investors Services
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- EMF Finance
- LXRX Health Care
- Exchange
- EMF Nasdaq
- LXRX Nasdaq
- Market Cap
- EMF 208.9M
- LXRX 228.8M
- IPO Year
- EMF N/A
- LXRX 2000
- Fundamental
- Price
- EMF $14.86
- LXRX $0.91
- Analyst Decision
- EMF
- LXRX Buy
- Analyst Count
- EMF 0
- LXRX 4
- Target Price
- EMF N/A
- LXRX $3.67
- AVG Volume (30 Days)
- EMF 29.3K
- LXRX 5.2M
- Earning Date
- EMF 01-01-0001
- LXRX 07-31-2025
- Dividend Yield
- EMF 6.16%
- LXRX N/A
- EPS Growth
- EMF N/A
- LXRX N/A
- EPS
- EMF N/A
- LXRX N/A
- Revenue
- EMF N/A
- LXRX $31,213,000.00
- Revenue This Year
- EMF N/A
- LXRX N/A
- Revenue Next Year
- EMF N/A
- LXRX N/A
- P/E Ratio
- EMF N/A
- LXRX N/A
- Revenue Growth
- EMF N/A
- LXRX 1251.21
- 52 Week Low
- EMF $10.58
- LXRX $0.28
- 52 Week High
- EMF $12.67
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- EMF 80.80
- LXRX 60.89
- Support Level
- EMF $13.71
- LXRX $0.80
- Resistance Level
- EMF $14.18
- LXRX $0.96
- Average True Range (ATR)
- EMF 0.23
- LXRX 0.08
- MACD
- EMF 0.05
- LXRX 0.01
- Stochastic Oscillator
- EMF 95.04
- LXRX 78.79
About EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.